Edwards Lifesciences Corp - Company Profile
Powered by 
All the data and insights you need on Edwards Lifesciences Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Edwards Lifesciences Corp Strategy Report
- Understand Edwards Lifesciences Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Edwards Lifesciences Corp (Edwards Lifesciences) develops, manufactures and markets products and technologies used for the treatment of structural heart disease and critically ill patients. It develops and commercializes heart valve products including heart valve systems and repair products, and hemodynamic monitoring systems.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Edwards Lifesciences conducts research to develop clinically advanced new products, enhance the effectiveness, safety and reliability of its existing products, and to expand the applications of major products. It has major investments in transcatheter structural heart programs, including clinical research for its mitral and tricuspid therapies business. The company focuses on the development of new products to enhance improve and streamline transcatheter aortic heart valve replacement procedures, and develop pulmonic platforms to expand therapies for congenital heart disease patients; develop technologies for the treatment of mitral and tricuspid valve diseases and other structural heart conditions, and minimally-invasive technologies for structural heart diseases; and development of decision support solutions for clinicians. The company has R&D facilities the US and Israel. The key R&D platforms include Resilia tissue integrity preservation technology, VFit technology and hypotension probability indicator technology. In FY2022, Edwards Lifesciences spent US$945.200 million on R&D activities, amounting to 17.5% of the company's revenue.
Product Categories
- Critical Care
- Surgical Structural Heart
- Transcatheter Aortic Valve Replacement
- Transcatheter Mitral and Tricuspid Therapies
Overview
Focuses on the development and commercialization of hemodynamic monitoring systems used to measure patient's heart function and fluid status in surgical and intensive care units. - Major products include noninvasive and minimally invasive devices, pediatric oximetry devices, tissue oximetry devices, venous oximetry devices, pulmonary artery catheters, volumetric, monitoring platforms and decision support software. Focuses on the development of decision support software suite with advanced algorithms, and a semi-closed loop system for management of patient fluid levels.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Focuses on the development and commercialization of surgical tissue heart valves and cardiac surgery systems - Key products include Carpentier-Edwards Perimount pericardial valve platform, surgical aortic valves, surgical mitral valves, replacement valves, annuloplasty rings and cardiac cannula devices Views acquisitions and product innovation as critical contributors to the growth of the segment.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Focuses on the development and commercialization of transcatheter heart valve replacement technologies designed for the minimally invasive replacement of heart valves. - Key products include Edwards Sapien XT, the Edwards SAPIEN 3 and SAPIEN 3 Ultra transcatheter aortic heart valves and delivery systems Intends to focus on indication expansions and technology advances; and continue to invest in trials beyond severe symptomatic aortic stenosis (AS) patients.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Develops transcatheter heart valve repair and replacement technologies to treat mitral and tricuspid valve diseases. - Key products include PASCAL transcatheter valve repair system, Cardioband systems for mitral and tricuspid valve repair, and annuloplasty ring and system Views product innovation as a critical factor for the growth of the category.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Target Markets
France, Germany, Italy, Spain, the UK and other European countries.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer